- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04923672
Exercise Preconditioning With Cancer Surgeries (ExPre 01)
Evaluation of the Feasibility of Wearable Technology-Guided Exercise Preconditioning to Accelerate Return to Function After Cancer Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
Research indicates that people who have better physical fitness at the time of surgery have a better chance of surviving the surgery and returning to normal function. An exercise intervention in the 3+ weeks before surgery (after the decision that surgery is necessary) may help people who are going to have abdominal surgery for cancer increase fitness prior to surgery. Devices that track physical activity, like smartwatches or Fitbits, allow the wearer to get feedback on physical activity information like steps taken, distance traveled, time in light, moderate or vigorous activity and on heart rate. Having this information and using a smartphone application designed to increase physical activity may help patients increase physical activity and thereby fitness, prior to abdominal surgery for cancer.
The main goal of this project is to test two physical activity interventions and also a "control group" to make sure that participants can do the interventions and to see whether there are changes in activity and fitness in each group:
- Control group - maintain current activity
- Moderate continuous activity group - increase activity to 5 days a week, 40 minutes per day, of continuous moderate activity
- High Intensity Interval Training group - increase activity to 5 days a week, 40 minutes per day, of intervals of moderate and vigorous activity
All participants will wear an Apple watch, and participants in the exercise groups will use a smartphone application to get feedback on activity and encouragement to reach activity goals.
Optional: Participants will also be asked to provide a small amount of blood for research purposes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ryan Gombita
- Phone Number: (434) 924-5529
- Email: KRA9HY@uvahealth.org
Study Contact Backup
- Name: Tarra Taylor
- Phone Number: (434) 243-8107
- Email: tot2g@uvahealth.org
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- Recruiting
- UVA Health System
-
Principal Investigator:
- Traci Hedrick, MD
-
Sub-Investigator:
- Robert Thiele, MD
-
Sub-Investigator:
- Laura Barnes, PhD
-
Contact:
- Ryan Gombita
- Phone Number: 434-924-5529
- Email: KRA9HY@uvahealth.org
-
Contact:
- Tarra Taylor
- Phone Number: 4342438107
- Email: tot2g@uvahealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (≥ 18 years of age) patients undergoing elective abdominal oncologic resection of a confirmed or potential colorectal, hepatobiliary, or gynecologic neoplasm.
- Study participants must be able to provide written informed consent and authorization.
- Study participants must be able to understand written and verbal English, as well as to be able to communicate in English.
- Study participants must have an Apple iphone to use during the study period
Exclusion Criteria:
- Any patient unable and/or unwilling to cooperate with all study protocols.
- Patients who require an assist device (walker) for ambulation.
- Patients that indicate they did at least 3 days of vigorous intensity activity in the previous 7 days OR any combination of walking, moderate-intensity or vigorous-intensity in all of the last 7 days totaling at least 18 and a half hours
- Recent history of cardiac disease (within 3 months of registration) that would preclude vigorous exercise
- Individuals with end stage renal disease currently on dialysis
- Individuals with a history of liver failure as evidenced by AST, ALT or Alkaline Phosphatase ≥ 3x upper limit of normal
- Individuals with uncontrolled hypertension
- Women who are breastfeeding or pregnant
- American Society of Anesthesiologists Physical Status score ≥ 4
- Any patient that needs further cardiac evaluation per ACC/AHA perioperative criteria
- Surgery scheduled < 3 weeks of study registration (precluding time to participate in exercise regimen)
- Any patient who currently uses a fitness tracker or heart rate monitoring-capable device to guide exercise
- Patient indicates a lack of familiarity or discomfort with using a smartphone
- If participation is not in the best interest of the patient, in the opinion of the treating investigator
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Participants will be asked to wear an Apple watch through about 30 days after surgery and will be asked to maintain their current activity level.
|
|
Active Comparator: Moderate continuous training group
Apple watch and a smartphone application Increase activity to 5 days a week, 40 minutes a day of continuous moderate intensity exercise prior to surgery. |
Participants will be asked to wear an Apple watch and use a smartphone application to help increase their activity to 5 days a week, about 40 minutes a day of continuous moderate intensity exercise prior to surgery.
They will be asked to continue wearing the watch through about 30 days after surgery.
|
Active Comparator: High intensity interval training group
Apple watch and a smartphone application Increase activity to 5 days a week, 40 minutes a day of intervals of high and moderate intensity exercise prior to surgery. |
Participants will be asked to wear an Apple watch and use a smartphone application to help increase their activity to 5 days a week, about 40 minutes a day of intervals of high and moderate intensity exercise prior to surgery.
They will be asked to continue wearing the watch through about 30 days after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Steps per day
Time Frame: Baseline through the 1 day visit prior to surgery
|
Change in average steps per day measured at baseline and at the time of surgery
|
Baseline through the 1 day visit prior to surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Enrollment rate
Time Frame: During participant accrual, estimated to take about 12 months
|
Number of participants enrolled per month
|
During participant accrual, estimated to take about 12 months
|
Compliance with EXi smartphone application
Time Frame: From baseline through 1 day visit just prior to surgery
|
To assess feasibility of the intervention
|
From baseline through 1 day visit just prior to surgery
|
Compliance with exercise intervention, including percentage of exercise goals reached
Time Frame: From baseline through 1 day visit just prior to surgery
|
To assess feasibility of the intervention
|
From baseline through 1 day visit just prior to surgery
|
Completion/Dropout rate
Time Frame: From baseline through about 30 days after surgery
|
To assess feasibility of the intervention
|
From baseline through about 30 days after surgery
|
Percentage of time wearing Apple Watch
Time Frame: From baseline through about 30 days after surgery
|
To assess feasibility of the intervention
|
From baseline through about 30 days after surgery
|
Health-related quality of life
Time Frame: Baseline and 1 day of surgery
|
As measured by PROMIS Global Health Scale
|
Baseline and 1 day of surgery
|
Pain intensity
Time Frame: Baseline and 1 day of surgery
|
As measured by PROMIS Pain intensity
|
Baseline and 1 day of surgery
|
Pain interference
Time Frame: Baseline and 1 day of surgery
|
As measured by PROMIS Pain interference
|
Baseline and 1 day of surgery
|
Physical activity level by self report
Time Frame: Baseline and 1 day of surgery
|
As measured by the International Physical Activity Questionnaire
|
Baseline and 1 day of surgery
|
Surgical complications
Time Frame: 30 days after surgery
|
Based on review of medical records
|
30 days after surgery
|
Length of hospital stay (in days) following surgery
Time Frame: Up to 30 days following surgery
|
Days participant stayed in hospital following surgery date
|
Up to 30 days following surgery
|
Steps per day
Time Frame: From baseline through 30 days after surgery
|
Measured by Apple Watch
|
From baseline through 30 days after surgery
|
Fitness level
Time Frame: Baseline, 1 day prior to surgery, and 30, 90, and 180 days following surgery
|
As measured by 6 minute walk test
|
Baseline, 1 day prior to surgery, and 30, 90, and 180 days following surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Traci Hedrick, MD, UVA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 210103
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecologic Cancer
-
University of LouisvilleJames Graham Brown Cancer CenterCompleted
-
Shandong UniversityCompletedGynecologic Cancer | Gynecologic DiseaseChina
-
Washington University School of MedicineWashington University Department of Psychological and Brain SciencesTerminatedStage III Gynecologic Cancer | Stage IV Gynecologic CancerUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedGynecologic Cancer | Surgery | Anesthesia | Hysterectomy | Gynecologic DiseaseItaly
-
Peking Union Medical College HospitalNot yet recruitingGynecologic Cancer
-
IRCCS Policlinico S. MatteoNot yet recruiting
-
Fudan UniversityGuangzhou Burning Rock Dx Co., Ltd.Recruiting
-
Fox Chase Cancer CenterCompleted
-
University Hospital, GenevaCompletedGynecologic CancerSwitzerland
-
Fudan UniversityGuangzhou Burning Rock Bioengineering Ltd.Active, not recruiting
Clinical Trials on Moderate continuous exercise
-
Riphah International UniversityCompletedHeart DiseasesPakistan
-
Instituto de Investigación Sanitaria de la Fundación...Completed
-
Norwegian University of Science and TechnologyLHL-Klinikkene, Røros; LHL-Klinikkene, FeiringWithdrawnVentricular Dysfunction, Left | Heart Failure, DiastolicNorway
-
University of North Carolina, Chapel HillNorth Carolina Diabetes Research CenterCompletedDiabetes Mellitus, Type 1United States
-
Technical University of MunichMedical University of Graz; Charite University, Berlin, Germany; Norwegian University... and other collaboratorsCompletedHeart Failure With Preserved Ejection FractionGermany, Belgium
-
McMaster UniversityCompleted
-
University of Alabama at BirminghamActive, not recruitingCognitive Dysfunction | HIV | Arterial StiffnessUnited States
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
Norwegian University of Science and TechnologyUMC Utrecht; Bispebjerg Hospital; Helse Stavanger HF; St. Olavs Hospital; University... and other collaboratorsCompletedHeart FailureNetherlands, Norway, Denmark, Belgium, Germany, Italy, Luxembourg
-
Hospital de Clinicas de Porto AlegreCompletedType 1 Diabetes Mellitus | Endothelial DysfunctionBrazil